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Abstract 
Purpose: To evaluate the use of two non-invasive and low-cost tests, orbital ultrasound 
and optical coherence tomography (OCT), in differentiating papilledema (PE) from 
pseudopapilledema (PPE). 
Methods: Retrospective cross-sectional analysis included 51 patients referred to a 
neuro-ophthalmologist for presumed PE who were diagnosed with PE (n = 23, median 
Frisen scale II) or PPE (n = 28, 13 buried drusen and 15 obliquely inserted optic nerves) 
based on a thorough history, ocular/neurological exams and ancillary tests. Orbital 
ultrasound consisted of a B-scan to detect buried drusen and a standardized A-scan to 
measure optic nerve sheath diameter (ONSD). If ONSD at primary gaze exceeded 
normal limits (4.2 mm), a 30° test was performed to measure the ONSD at 30° lateral 
gaze. A Cirrus OCT Optic Disc Cube 200x200 scan was used to obtain the retinal nerve 
fiber layer thickness (RNFLT).  
Results: The mean ONSD (mm) at primary gaze was larger in PE (5.4 ± 0.6) than PPE 
(4.0 ± 0.3, p < 0.0001).  The percent change in the ONSD at 30° gaze was greater in PE 
(22.4 ± 8.4) than PPE (2.8 ± 4.8, p < 0.0001).  Average RNFLT (µm), was thicker in PE 
(219.1 ± 104.6) than PPE (102.4 ± 20.1, p< 0.0001).  ONSD and 30° test had the 
greatest area under the ROC curve (AUC), 0.98 and 0.97, respectively; followed by 
inferior quadrant (0.90) and average RNFLT (0.87). In a subgroup of mild PE (Frisen 
scale I-II, n = 15), AUC remained high for ONSD (0.95) and 30° test (0.93) but 
decreased to 0.71 for average RNFLT. At 95% specificity, sensitivity (%) for ONSD, 30° 
test and average RNFLT was 91.3, 91.3 and 56.5, respectively for the entire PE group; 
80.0, 86.7 and 13.3 for the mild PE subgroup. 
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Conclusion: Orbital ultrasound and OCT are useful ancillary tests that can be done, 
along with a thorough examination, to effectively differentiate PE from PPE.  Due to its 
easy access, RNFLT can potentially be used to detect moderate to severe PE.  
Ultrasound measurements may further assist eye care providers in differentiating mild 
PE from PPE when ophthalmoscopic findings are non-diagnostic. 
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Chapter 1: Introduction 
 
1. Background 
Papilledema (PE), optic disc edema secondary to increased intracranial pressure 
(ICP), indicates potentially life-threatening conditions such as intracranial masses, 
cerebral venous thrombosis, cranial injuries, subarachnoid hemorrhages, meningitis, and 
idiopathic intracranial hypertension (IIH) that require urgent medical management (1). 
Clinical history and ophthalmological findings are vital for the correct diagnosis. 
Increased ICP within the optic nerve sheath causes axoplasmic flow stasis, resulting in 
edema of the axons within the optic nerve head (2, 3). PE typically presents bilaterally, 
but can be asymmetrical or even unilateral (1, 4, 5). Prolonged PE can lead to 
permanent and severe vision loss (6).  On ophthalmoscopy, PE may exhibit signs such 
as optic nerve head elevation, blurred optic disc margins, venous congestions, 
hemorrhages, soft/hard exudates, and choroidal/retinal folds (7). While ophthalmoscopy 
is a routine clinical procedure to detect optic disc edema, its accuracy depends on the 
severity of PE and the expertise of the clinician.  Subtle PE can be especially difficult to 
accurately diagnose; and may be easily confused with pseudopapilledema (PPE), a 
group of benign conditions mimicking disc edema including optic nerve head drusen, 
nasally elevated nerves or crowded hyperopic discs, due to the presence of overlapping 
ophthalmic signs (e.g. disc elevation and blurry margins) in both PPE and PE. Systemic 
and visual symptoms associated with increased ICP and PE such as headache, nausea, 
vomiting, pulsatile tinnitus, transient visual obscuration, or diplopia are not necessarily 
specific or present in patients with PPE; abnormal visual acuity, pupillary responses, 
color vision or visual field defects (other than enlarged blind spots) are uncommon in 
acute PE (1). On the other hand, patients with PPE may have unrelated headaches, 
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visual disturbances or visual field defects that further complicate a clinician’s decision 
making (8, 9).   
In order to avoid ordering a costly and sometimes invasive neurological work-up 
in patients with PPE (10), ancillary testing such as optical coherence tomography (OCT) 
(11), orbital ultrasound (12, 13), and fluorescein angiography (14) has been utilized to 
improve diagnostic accuracy.  The goal of this thesis is to evaluate the diagnostic 
abilities of orbital ultrasound and OCT in PE and PPE patients.   
2. PE 
2.1 Pathophysiology 
 Ever since Türck and Coccius first described PE independently in 1853, many 
have theorized about the underlying pathophysiology (15).  In the mid-1800s, Türck 
(1853) and Von Graefe (1860) thought that in patients with cerebral tumors, venous 
stasis of the cavernous sinus secondary to increased ICP would mechanically cause a 
stagnation of blood flow in retinal veins, resulting in optic disc edema (15, 16).  In 1898, 
Deyl proposed that in PE, the central retinal vein, which pierces the subarachnoid space 
in its course, becomes occluded as pressure in the perioptic subarachnoid space 
increases, thus leading to hyperemia and edema of the optic nerve (17). Many 
contradictory theories, both mechanical and non-mechanical in nature, existed without 
experimental support. It was not until 1960’s that Hayreh conducted a series of 
anatomical and physiological studies in human cadavers and rhesus monkeys to 
understand the mechanism of PE (18).    In 1965, Hayreh investigated the role of central 
retinal vein compression by cauterizing the central retinal vein where it exists the optic 
nerve sheath in six rhesus monkeys (19, 20). The funduscopic examination in three of 
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the monkeys did not show any optic disc edema (group I), while the other three did show 
some hyperemia of the nerve (group II). Hayreh then artificially elevated the ICP using 
an inflatable balloon placed inside the cranium in two monkeys (one from each group). 
Increased ICP successfully induced bilateral optic disc edema in the monkey from group 
I.  The group II monkey exhibited marked disc edema in the fellow non-cauterized eye 
but only segmental edema of the disc when the ICP was elevated.  Upon 
histopathological examination of the group II monkey, it was discovered that a segment 
of the optic nerve had been accidently cauterized, causing optic atrophy in the region.  
The atrophied part of the optic nerve did not exhibit any edema when the ICP was 
increased.  Thus Hayreh disproved the idea that compression of the central retinal vein 
plays a primary role in the pathogenesis of PE, a prevalent belief at the time, and 
learned that intact nerve fibers must be present in order for PE to occur. 
 Upon anatomical examination, Hayreh discovered that the subarachnoid space 
between the optic nerve and its sheath is largest immediately behind the globe and 
narrowest in the region of the optic canal (19).  He also established that successful 
transmission of the increased intracranial cerebrospinal fluid (CSF) pressure to the optic 
nerve sheath is a pre-requisite for developing optic disc edema because cutting open the 
retrobulbar optic nerve sheath (sheath fenestration) in rhesus monkeys prevented the 
development of optic disc edema when the ICP was raised. Hayreh (1977a,b) 
documented the evolution of PE in rhesus monkeys using stereoscopic color fundus 
photography and fluorescein angiography (2, 21). On stereoscopic fundus photography 
the first notable finding was elevation (swelling) of the optic disc at the lower pole, 
followed by the superior disc, then the nasal disc, and lastly the temporal disc. The 
blurring of the optic disc margin was the next sign (observed after “appreciable amount 
of optic disc edema”), followed by hyperemia of the optic disc, and late vascular changes 
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including capillary dilation, microaneurysms, hemorrhages, and venous engorgement. 
According to Hayreh, stereoscopic fundus photography was much more sensitive in 
detecting early optic disc edema than fluorescein angiography, which detects the 
vascular changes occurring later in the process, confirming that vascular changes are 
secondary to optic disc swelling. 
 Tso and Hayreh also conducted a series of histopathological studies on rhesus 
monkeys to further understand the pathogenesis of PE (3).  Initially, they used light 
microscopy studies to confirm that prominent axonal swelling in the optic disc surface 
and the anterior part of the prelaminar region was a major factor in PE and believed it to 
be responsible for the edema seen on ophthalmoscopy.  They then used horseradish 
peroxidase, injected intravenously, to show blood vessel leakage at the posterior part of 
the nerve fiber layer, prelaminar and laminar cribrosa regions; they concluded that  optic 
disc edema reflects a combination of axonal swelling and fluid leakage from the blood 
vessels.  Lastly, Tso and Hayreh injected tritiated leucine intravitreously and observed 
via autoradiographs of the optic nerve head that stasis of the axoplasmic flow is primarily 
the cause of axonal swelling (22).  Thus, Hayreh concluded that the pathogenesis of PE 
is primarily a mechanical phenomenon. The increased CSF pressure is first transmitted 
to the perioptic subarachnoid space causing axoplasmic flow stasis, which leads to 
swelling of the nerve fibers and therefore the optic disc edema.  The swelling of the optic 
nerve head then secondarily compresses the venules, which results in vascular changes 
such as venous stasis and fluid leakage.  Optic disc edema in the setting of increased 
ICP represents a combination of swollen axons and the extracellular fluid leakage from 
blood vessels in the region.    
2.2 Frisen Scale 
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The modified Frisen scale uses the optic nerve appearance via ophthalmoscopy 
to assess the degree of PE (23, 24).  The hallmark sign of grade I is a C-shaped halo 
that has a temporal gap, grade II shows a circumferential halo, grade III is obscuration of 
one or more segments of major blood vessels leaving the optic disc, grade IV is 
obscuration of a major blood vessel on the disc, and grade V is complete vessel 
obscuration. The Frisen scale is limited because it is an ordinal scale.  Also, it is a 
subjective evaluation and grading of PE, which can significantly vary among individuals, 
thus objective evaluation of PE, such as OCT, may prove to be useful over time (24).   
3. PPE 
PPE is a benign optic nerve head elevation, which can be caused by small 
crowded hyperopic discs, obliquely inserted discs, and optic disc drusen.   
3.1 Tilted Optic Disc and Obliquely Inserted Discs 
Tiled optic discs and obliquely inserted optic discs can be mistaken for mild PE 
due to bilateral, segmental elevation of the optic nerve (25).  Tilted optic discs occur in 
0.4 to 3.5% of the general population (25) and are thought to be associated with an 
incomplete closure of the fetal fissure (26).  Indistinct margins and elevation of the tilted 
optic disc are most commonly in the superotemporal quadrant of the optic disc (27, 28), 
whereas obliquely inserted nerves are most commonly elevated nasally.  Patients with 
either of these conditions are usually asymptomatic, but if they present with a non-
specific symptom of headache or visual disturbance further testing may be required to 
rule out mild PE.   
3.2 Small Crowded Discs and Myelinated Optic Discs 
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The small cup to disc ratio, elevated appearance, and indistinct borders of the 
small, crowded optic discs, generally seen in hyperopic patients with a shorter axial 
length (29), attribute to the challenge in properly diagnosing PPE. Small, crowded optic 
discs are usually around 1.95 ± 0.33 mm in size (30), whereas normal optic disc size are 
2.69 ± 0.70 mm (31).  Circumferential, bilateral myelinated discs can imitate PE as well, 
as it presents as an elevated disc, with indistinct margins and obscured vessels.  
However, this is a rare occurrence, as only 0.6 to 1% of people have myelination of 
nerve fiber layer anterior to the lamina cribrosa, and only 0.8% of the time are these 
findings bilateral (32).  
3.3 Optic nerve head drusen 
Optic nerve head drusen, which has a prevalence of 3.4 to 24 per 1,000 
population (33), are calcified acellular bodies, consisting of mucopolysaccharides, amino 
acids, DNA, RNA, and iron (34) located anterior to the lamina cribrosa (35).  They are 
most often in the nasal portion of the optic nerve head (36). The pathogenesis of optic 
nerve head drusen is not fully understood at this time, but there are theories.  Tso (1981) 
suggests that an initial alteration in axoplasmic flow leads to intracellular mitochondrial 
calcification (37).  Next, axonal degeneration leads to the deposition of calcium, 
presumably from mitochondria, and the formation of drusen.  Another theory suggests 
that the abnormal vasculature seen in patients with optic nerve head drusen, such as 
abnormal tortuosity, dilated veins, and retino-choroidal collaterals may contribute to the 
formation of drusen by excessive deposition of plasma proteins (38, 39).  Others have 
suggested that a smaller scleral canal can cause axoplasmic stasis through optic nerve 
compression (40), but Floyd et al measured scleral canals using OCT and determined 
that scleral canal size is probably not a factor in the pathogenesis of optic nerve head 
drusen (41).  Further investigation is required to fully understand its pathogenesis.   
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Optic nerve head drusen can have various presentations. Those visible on 
ophthalmoscopy are termed surface drusen, whereas drusen not visible on 
ophthalmoscopy are buried drusen.  Optic nerve head drusen can cause optic nerve 
head elevation and indistinct margins mimicking PE.  Optic nerve head drusen can 
present bilaterally (42, 43) or unilaterally (42), and they can be small or large, ranging 
from 5-1000µm (34, 37).  Optic nerve head drusen are thought to be inherited in an 
irregular dominant fashion (44), and typically begin in the younger patients as a buried 
drusen (42). Longitudinal studies have shown that buried drusen can migrate forward to 
become surface drusen (45). Surface drusen are easier to classify as PPE upon 
stereoscopic examination, thus our study will only evaluate buried drusen. 
The difficulty in differentiating between optic nerve head drusen and PE, besides 
the funduscopic similarities, occurs when drusen patients, who are usually 
asymptomatic, present with visual field defects (46, 47), transient visual obscurations 
(TVOs) (33), or decreased visual acuity (48).  Visual fields defects, most commonly 
enlarged blind spots or arcuate defects, appear in the second decade of life (49) and can 
progress mildly with age (50).  Although visual field defects occur in 25-71% of patients, 
severe field loss and decreased in visual acuity are rare but can occur (48).  Vision loss 
and TVOs are attributed to permanent or transient compromise of the vascular integrity 
of the optic nerve head, caused by the compressive effects of drusen (51).  Even though 
PE and PPE can present similarly, it is vital that clinicians diagnose drusen correctly to 
avoid unnecessary invasive testing; therefore, we will next discuss the role of a thorough 
history in differentiating PE and PPE.  
4. Symptoms of Elevated ICP 
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Many patients with elevated ICP have idiopathic intracranial hypertension (IIH), a 
condition of high ICP without identifiable brain or CSF abnormalities.  The incidence of 
IIH is 1 in 100,000 in the general population and rises to 19.3 per 100,000 in obese 
female of childbearing age (52). Studies on IIH allow us to evaluate the symptoms 
involved in elevated ICP. 
4.1 Headaches 
In IIH, headaches are the most common presenting symptom, occurring in 84-
94% of patients (53, 54).  The headaches typically occur daily, are diffuse and might be 
so severe in nature that they may awaken the patient during sleep or exist with nausea 
(55). Studies have found that headaches associated with IIH are not distinguishable from 
tension headaches (56) or migraine (57-59).  Headaches as a non-specific sign can 
cause problems when they present in a patient with PPE.  A recent study by Kovarik et 
al (2015) reported 25 of the 34 pediatric patients referred for suspected PE had 
headaches, and 26 of them were determined to have PPE (60).   
4.2 TVOs 
Transient visual obscurations are episodes of transient blurred or loss of vision. 
TVOs in PE typically occur for less than 30 seconds and may be associated with 
postural changes.  As discussed above in optic nerve head drusen, transient ischemia of 
the optic nerve is thought to contribute to TVOs in both PE and PPE (51, 61).  TVOs 
have been shown to be useful in distinguishing between PE and PPE, as the occurrence 
of TVOs in PE patients (68%) is greater than in PPE and controls(13, 53). However, 
patients could be confused by TVOs associated with PE versus those from other causes 
(e.g., dry eyes).   
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4.3 Pulsatile Tinnitus 
Pulse synchronous tinnitus, described as a whooshing sound, occurs in 52-58% 
of patients with elevated ICP and is useful in diagnosing PE (53, 54).  The 
pathophysiology is not fully understood, but some postulate that it is due to alterations in 
the cerebral vasculature.  For example, a patient with elevated ICP secondary to a 
unilateral venous stenosis has increased blood flow through the contralateral sinus 
causing the patient to hear the pulsating, whooshing sound (62).  
4.5 Other symptoms 
Retrobulbar pain (44%), diplopia (38%), and visual loss have also been reported 
in patients with elevated ICP (63). The sixth cranial nerve becomes vulnerable to the 
effects of elevated ICP as it passes over the petrous portion of the temporal bone.  Sixth 
nerve palsy, found in 10-20% of patients with elevated ICP, can cause horizontal 
diplopia(55).  The optic nerve can also be affected if the ICP is not controlled causing 
vision loss secondary to atrophy of the optic nerve (6).  
 All disc elevations are not necessarily due to edematous nerves and all PPE 
patients are not asymptomatic, in fact many of the symptoms from elevated in ICP are 
common in PPE or controls, thus we will investigate the role of ancillary testing, 
specifically orbital ultrasound and OCT, in differentiating PE and PPE. 
5. Orbital Ultrasound 
Orbital ultrasound helps diagnose PE by measuring the optic nerve sheath 
diameter (ONSD), which enlarges with elevated ICP.  In recent years, neuro-intensive 
care providers have used B scans due to their relative ease of use, to measure the 
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ONSD and they have reported correlation between the enlarged ONSD and the 
increased ICP in patients with invasive ICP monitoring (64-66). Human postmortem and 
in vivo studies have shown that the retro-bulbar part of the optic nerve sheath, being 
surrounded by orbital fat only, expands quickly in response to CSF pressure elevation 
transmitted from the intracranial subarachnoid space (67, 68).  Interestingly, in the field 
of ophthalmic ultrasonography, the recognized technique for detecting fluid around the 
retro-bulbar optic nerve is based on standardized A-scan procedures. In the early 1970s, 
Dr. Ossoinig first described standardized echography, which incorporates a special S-
shaped amplifier and a calibration for tissue sensitivity, and stated that the most 
accurate means to measure ONSD with ultrasound is to use standardized A-scan (69, 
70). He also introduced the 30° test to differentiate an enlarged ONSD secondary to 
increased subarachnoid CSF from other solid or infiltrative optic nerve lesions such as 
meningioma or glioma. When an enlarged ONSD is encountered, the 30° test is 
performed by comparing the A-scan measured ONSD at primary gaze to that at 30° 
lateral gaze.  A reduction in the widening of the ONSD at lateral gaze is presumed to 
occur due to redistribution of the increased amount of CSF over a greater area. In the 
presence of a large amount of fluid, a 25% to 30% reduction in ONSD has been 
observed (71, 72).  
 The A-scan has been shown to be useful in differentiating between PE and PPE 
in children (12) and adults (13).  Using A-scan, sensitivity has ranged from 85-90% and 
the specificity has ranged from 63-79%.  The problem with A-scan to measure ONSD 
and perform the 30° test is that the technique requires extensive training and experience 
from the examiner.  It is estimated that there are only around 150 trained orbital 
ultrasonagraphers in the USA (13).   
 Another use of orbital ultrasound is to detect optic nerve head drusen. Buried 
drusen are not detectable by ophthalmoscopy alone (43); however, they do contain 
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calcium, which is highly reflective upon autoflourescence, B-scan and CT scan imaging 
(40, 71, 73, 74). Of these three tests, B-scan is considered the most reliable  in 
diagnosing buried drusen (75).  
 
6. OCT  
Ocular imaging over the past several years has increased in significance in 
diagnosing ocular diseases.  Optical coherence tomography has emerged in many 
optometric/ophthalmologic practices because of its easy and quick use.  Specifically, the 
high definition spectral domain (SD) OCT has allowed the optic nerve head to be 
analyzed both qualitatively and quantitatively, and has been utilized in differentiating 
between PE and PPE.   
6.1 PE 
Quantitatively, OCT has been used to demonstrate increased retinal nerve fiber 
layer (RNFL) thickness (RNFLT) in acute PE (11, 76-79), however, RNFL thinning 
occurs in chronic PE (80).  A few studies have reported that the nasal quadrant may be 
the most useful in differentiating between PE and buried drusen (77, 79).  Drusen most 
commonly occur in the nasal quadrant (36, 38) and can cause atrophy of RNFL nasally 
(78).  In PE, the nasal RNFLT is thickened (11, 76, 78, 79), therefore, this quadrant may 
prove to have the greatest diagnostic value.  Papillary elevation, another quantitative 
measure, was shown by Flores et al to be useful in distinguishing between PE and PPE 
(78).   
There are other OCT measurements that have been assessed in detecting PE.  
For example, Kupersmith et al evaluated the retinal pigment epithelium (RPE)/Bruch’s 
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membrane angulation with OCT, and found an inward angulation toward the vitreous in 
67% of PE patients (81).  Other measurements such as peripapillary total retinal 
thickness (TRT) have been studied. Several studies have shown that measuring TRT 
has a role in assessing severe PE, as it may have less machine algorithm failure in 
segmentation (24, 82).  At this point it is not certain whether TRT will aid in differentiating 
subtle PE from PPE.  Vartin et al concluded that TRT may help to increase the sensitivity 
to mild PE (83), but Bassi et al found that the average RNFLT and individual quadrant 
measurements  (AUC = 0.63 - 0.79) performed slightly better than TRT (0.58 -0.60) in 
diagnosing PE (11). Two studies that have looked at both quantitative and qualitative 
OCT measurements in PE proved quantitative measures to have a greater diagnostic 
ability (76, 78).  However, the difficulty in analyzing most of the studies that utilize OCT 
in differentiating PE and PPE, is that many authors have included optic neuritis and 
ischemic optic neuropathies in their optic disc edema groups, thus the results are not 
truly representative of the true PE population.  To our knowledge there are only two 
studies that have evaluated the use of SD-OCT in differentiating between PE and PPE 
(11, 84).  Bassi and Mohana found OCT to be useful (11), whereas a smaller study by 
Kulkarni et al (84), evaluating mild PE only, suggested that OCT was not reliable.  Our 
study will seek to confirm if the quantitative measurements of OCT, such as RNFLT, are 
useful in detecting PE.   
6.2 PPE 
Savini et al (2006) and Johnson et al (2009) suggested the use of the OCT 
qualitatively to observe the subhyaloid hyporeflective spaces, paying particular attention 
to the internal contour of the optic nerve (76, 85).  They used the terms ‘lumpy bumby’, 
to describe optic nerve head drusen, or ‘lazy V’, to describe PE. Lee et al (2011) 
proposed that high definition SD-OCT also allows the visualization of optic nerve head 
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drusen as hyperreflective papillary subretinal focal masses (77).  Bassi and Mohana 
found that 100% of eyes with optic nerve head drusen (n = 19) showed a hyperreflective 
mass (11).  
However, recent evidence suggested that optic nerve head drusen have a variety 
of presentations, depending on their size and location, and the age of the patient (86).  It 
is difficult to diagnose optic nerve head drusen based on OCT alone, as the disc drusen 
can present as hyperreflective masses (77), hyporefelctive masses (87), increased 
RNFLT (86), decreased RNFLT (78), or even as normal in children (11).  Interestingly, 
with the advent of enhanced depth imaging (EDI) OCT and swept source (SS) OCT, the 
ability to detect optic nerve head drusen may improve (88-90). 
For small crowded discs versus mild PE, OCT was unable to accurately 
differentiate between the two (91), but for tilted optic discs OCT may prove to be useful 
as tilted optic discs show a decrease in RNFLT (27) whereas mild PE may show an 
increase.  
7. The Current Study 
Previous studies have examined the role of OCT RNFL thickness or A-scan 30° 
test individually in differentiating PE and PPE (11-13, 84).  Although each technique is 
shown to be useful, there is variable sensitivity (63 to 77% for OCT, 85 to 90% for 
ultrasound) and specificity (55 to 71% for OCT, and 63 to 79% for ultrasound) across 
studies.  It is also important to note that performing the 30° test with A scan requires 
great expertise whereas OCT is more easily done, and accessible in many clinics. 
Comparing the diagnostic performance of OCT and A-scan in PE and PPE in the same 
patients would allow us to understand the strengths and limitations of each technique, 
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and help us establish a diagnostic protocol. In our neuro-ophthalmology clinic, all 
patients with suspected PE or PPE underwent ultrasound evaluation by an examiner 
with over 30 years of experience in ophthalmic ultrasound techniques. To our 
knowledge, the present study is the first to include both SD-OCT and standardized A-
scan on the same patients.  
The aim of the current study was to evaluate and compare the utilization of 
orbital ultrasound and SD-OCT in differentiating PE and PPE patients. Specifically, the 
diagnostic performance of RNFLT, ONSD, and 30° test were examined. Although it is 
not expected to be useful for differential diagnosis, the macular ganglion cell inner 
plexiform (GCIP) thickness was included to evaluate retinal ganglion cell damage in PE 
and PPE patients. 
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Chapter 2: Methods 
Subjects 
A retrospective review of medical records from 2013 through 2015 from the 
University of Houston College of Optometry MS Eye CARE Clinic identified 23 subjects 
(mean age: 29.9 ± 11.0 years) with a definitive diagnosis of PE and 28 subjects (mean 
age 28.6 ± 11.8 years) with PPE, all referred for presumed PE. All patients underwent at 
least an initial comprehensive neuro-ophthalmologic examination that included dilated 
fundus examination by an experienced neuro-ophthalmologist, OCT, and an ultrasound 
evaluation of the optic nerve. Depending on the suspected etiology, further diagnostic 
work up might have included neurological evaluation with brain/orbital imaging, lumbar 
puncture, and other necessary tests (1, 10). In the PE group, all 23 subjects were 
diagnosed with IIH.1 In the PPE group, 13 subjects showed buried optic disc drusen on 
B-scan and 15 subjects showed nasal elevation due to oblique insertion of the optic disc.  
Patients with a previous history of PE or those with ocular or systemic conditions that 
could potentially influence OCT/ONSD measurements were excluded.   
Orbital Ultrasound 
  All ultrasound examination was performed by a very experienced examiner with 
the Aviso S system (Quantel Medical).  B scan (10 MHz probe) was initially used to rule 
out buried optic nerve head drusen. Standardized A scan was used to measure the 
ONSD as described by Ossoinig and his colleagues (69, 70); the largest measurement 
with repeated measures was recorded. The A-scan seen in Figure 1 shows the initial 
probe spike (IP), followed by an area of minimal to no spikes, as sound travels through 
the vitreous (V), followed by the large spikes of the optic nerve sheath (S1 and S2).  The 
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spikes from the sheath should be equal in amplitude and should have no major spikes in 
between them.  If ONSD exceeded the lab-established normal limit (4.2 mm), the 30° 
test was performed. The reduction in ONSD measured at 30° lateral gaze compared to 
that at primary gaze was calculated as a percentage. A greater than 20% decrease in 
sheath diameter was considered a positive 30° test by our ultrasonagrapher. Figure 1 
shows an example of the ONSD decreasing from the primary gaze (A) to the 30° gaze 
(B), presumably due to redistribution of the increased subarachnoid fluid over a larger 
area in PE. 
 
 
 
 
 
 
 
 
Figure 1. The A-scan shows the initial probe spike (IP), followed by an area of no spikes, 
as sound travels through the vitreous (V), followed by the optic nerve sheath (S1 and S2).  
The spikes from the sheath should be equal in amplitude and should have no major 
spikes in between them.  An example of ONSD decreasing from the primary gaze (A) to 
the 30o gaze (B), presumably due to redistribution of increased subarachnoid fluid over a 
larger area.   
OCT 
A            ONSD = 5.85 mm B            ONSD = 3.72 mm 
IP 
S1 S2  S1 S2 
IP 
V V 
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OCT was performed using Cirrus-HD OCT 4000 version 6.5 (Carl Zeiss Meditec 
Inc, Dublin, CA) by a trained ophthalmic technician. The average (avg) and quadrant 
peripapillary RNFLT data were obtained using the Optic Disc Cube 200 × 200 protocol 
that images the optic disc in a 6 mm x 6 mm area centered on the optic nerve.  The 
average macular ganglion cell inner plexiform layer thickness (GCIPT) data were 
obtained using the Macular Cube 512 × 128 protocol that images a 6 mm × 6 mm area 
centered at the fovea. The machine software derived the GCIPT automatically for an 
elliptical annulus (2 mm × 2.4 mm radius), that excluded the central foveal region (0.5 
mm × 0.6 mm radius). All OCT images had signal strength ≥ 7 and good centration, and 
were inspected for segmentation errors. Of the 23 PE patients, macular scans in 6 
patients (both eyes in 3 of them, and the worse eye in the other 3 patients) showed 
erroneous segmentation for GCIPT upon visual inspection and were excluded (Figure 2). 
The avg or quadrant RNFLT and avg GCIPT were considered abnormally thickened 
when their values exceeded 95% of the age-matched machine normative database. 
 
Statistics 
 Statistical analyses were performed using STATA 14.1 (StataCorp LP, College 
station, TX).  For each subject, the eye with thicker RNFLT was selected for statistical 
analysis. Two-sample t-test was used to compare the means of various OCT and orbital 
ultrasound measures between the PE and PPE groups. Two proportion z-test was used 
to compare the percentages. The relationship between different variables, for example, 
RNFLT vs ONSD, RNFLT vs ICP for patients with PE was evaluated using Spearman 
Rho. Receiver operating characteristic (ROC) curves were constructed in Sigmaplot 10.0 
(Systat Software, Inc) to evaluate the diagnostic performances of OCT and ONSD 
parameters. P values less than 0.05 were considered statistically significant.
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Chapter 3: Results 
Patients’ clinical characteristics 
Table 1 summarizes patient characteristics for PE and PPE groups. Of the 51 
patients referred in for presumed PE, 23 were diagnosed with PE (median Frisen scale 
2) and 28 with PPE (13 buried drusen and 15 nasally tilted nerves).  The mean age was 
similar between PE (29.9 ± 11.0) and PPE groups (28.6 ± 11.8, p = 0.69).  There were 
more females than males in the PE group (21: 2) than the PPE group (14:14) (p = 
0.0016), as well as a greater number of obese individuals (BMI > 30) in the PE group 
(78%) than the PPE group (25%) (p = 0.0002).  The most common symptoms in the PE 
group were headache (91%), transient visual obscurations (61%), and tinnitus (35%).  
All PPE patients had at least one symptom; with the most common being headache 
(86%), followed by transient visual obscurations (57%) and tinnitus (21%). There were 
no statistical differences in the prevalence of the above-mentioned symptoms between 
the two groups. 
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Table 1: Comparison of demographic and clinical characteristics 
 
 Papilledema (n = 23) Pseudopapilledema (n = 28) 
Age (years)* 29.9±11.0 28.6±11.8 
F:M 21:2 14:14 
Obese (BMI>30) 18 (78%) 7 (25%) 
LP OP (cmH20)* 31.0±9.9 NA 
Buried drusen NA 13 (46%) 
Nasally tilted NA 15 (54%) 
Frisen scale (n) † I (3), II (9), III (5), IV (6)  
Symptoms   
Headache 21 (91%) 24 (86%) 
TVO 14 (61%) 16 (57%) 
Tinnitus 8 (35%) 6 (21%) 
Double vision 1 (4%) 0 (0%) 
Eye pain 1 (4%) 1 (4%) 
VA 20/20 or better 23 (100%) 27 (96%) 
 
*mean ± SD; †based on the worse eye in asymmetrical PE cases; 
LP OP: lumbar puncture opening pressure; TVO: transient visual obscuration  
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Comparing ultrasound and OCT measurements between PE and PPE 
The mean ONSD (mm) at primary gaze was larger in PE (5.4 ± 0.6) when 
compared to PPE (4.0 ± 0.3, p < 0.0001) (Table 2).  On the 30° test, a larger percentage 
of reduction in ONSD was observed in the PE group (22.4% ± 8.4) than in the PPE 
(2.8% ± 4.8, p < 0.0001).  
The mean avg RNFLT (µm) was increased in PE (219.1 ± 104.6) when 
compared to PPE (102.4 ± 20.1, p < 0.00001 for all) (Table 2). The respective quadrant 
RNFLT for PE and PPE was 277.7 and 122.9 superiorly, 173.6 and 80.4 nasally, 281.0 
and 136.8 inferiorly, and 121.3 and 66.1 temporally. Six PE eyes (26%) had the GCIP 
inaccurately segmented by the machine algorithm causing an artificially thin GCIP layer 
thickness despite strong signal strength. After excluding the inaccurately segmented PE 
eyes, GCIP thickness (µm) was slightly decreased in PPE (80.9 ± 13.1) when compared 
to PE (86.0 ± 5.5, p < .04). 
Compared to age-matched machine norms, more PE eyes (56.5% to 87.0%) 
showed abnormal RNFL thickening than PPE eyes (14.3% to 25.0%).  The inferior 
quadrant showed the greatest percentage (87.0%) followed by the avg RNFLT and 
superior quadrant (69.6% for both).  
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Table 2: Comparisons of ultrasound findings and OCT findings for PE and PPE 
 
	 Papilledema  
(n = 23) 
Pseudopapilledema  
(n = 28) 
p 
ONSD (mm) at primary gaze 5.4±0.6 4.0±0.3 < 0.0001 
ONSD change at 30° gaze (%) 22.4±8.4 2.8±4.8 < 0.0001 
    % (+) with >10%* 91.3 14.3 	
    % (+) with >13.5%† 91.3 3.57 	
    % (+) with >20%‡ 82.6 0.00 	
Avg RNFLT (µm) 219.1±104.6 102.4±20.1 < 0.0001 
     range (µm) 102-426 60-168 	
     % thickened§ 69.6 25.0 0.001 
Superior RNFLT 277.7±158.7 122.9±31.3 < 0.0001 
     % thickened§ 69.6 14.3 0.001 
Nasal RNFLT 173.6±101.4 80.4±37.4 0.0001 
     % thickened§ 65.2 17.9 0.0006 
Inferior RNFLT 281.0±146.5 136.8±29.7 <0.0001 
     % thickened§ 87.0 21.4 <0.0001 
Temporal RNFLT 121.3±63.6 66.1±13.2 <0.0001 
     % thickened§ 56.5 14.3 0.001 
GCIPT (µm) 86.0±5.5 80.9±13.1 0.04 
     % inaccurately segmented 26.1 0.0 	
*a commonly suggested criterion (71);  †based on ROC analysis (Table 3);  ‡based on 
our ultrasonagrapher’s experience; §thicker than the age-matched machine norms; 
ONSD: optic nerve sheath diameter 
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Receiver Operating Characteristic (ROC) analysis 
In Figure 3, each ROC curve was constructed by plotting Sensitivity (the true 
positive rate where PE eyes were correctly classified) against 1 – Specificity (the false 
positive rate where PPE eyes were misclassified as PE) when the parameter’s threshold 
value was varied. Of all the ultrasound and OCT measurements, the ONSD and the 30° 
test had the greatest area under the curve (AUC), 0.98 and 0.97, respectively; followed 
by the inferior quadrant  (0.90), and the avg RNFLT (0.87) (p < 0.0001 for all) (Table 3).  
The AUCs for the ONSD and the 30° test were significantly different from that of the avg 
RNFLT (p = 0.013 and 0.015, respectively), but did not reach statistical difference when 
compared to that of the inferior RNFLT (p = 0.05 and 0.08, respectively). The ONSD and 
the 30° test showed the same sensitivity (91.3%) and specificity (96.4%) with a cutoff 
value of 4.59 mm and 13.50%, respectively.  At 96.4% specificity, the sensitivity was 
56.5%, 52.2%, 69.6%, 43.5% and 56.5% for the avg, inferior, superior, nasal and 
temporal RNFLT, respectively. The GCIP showed no diagnostic value in differentiating 
between PE and PPE (AUC = 0.6429, p = 0.114).    
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Table 3: Diagnostic performance for ultrasound and OCT in differentiating PE from PPE 
 
 
AUC 
(95% CI) 
Cutoff 
value 
Sensitivity%* 
(95% CI) 
LR+ LR- 
ONSD 
0.98 
(0.95-1.00) 
 4.59 mm 
91.3 
(72.0-98.9) 
25.6 0.09 
30o test 
0.97 
(0.94-1.01) 
13.50% 
91.3 
(72.0-98.9) 
25.6 0.09 
Avg 
RNFLT 
0.87 
(0.77-0.96) 
156.0 µm 
56.5  
(34.5-76.8) 
2.1 0.29 
S 
0.83 
(0.71-0.95) 
163.5 µm 
69.6 
(47.1-86.8) 
9.7 0.33 
N 
0.83 
(0.71-0.95) 
197.0 µm 
43.5 
(23.2-65.5) 
4.1 0.3 
I 
0.90 
(0.82-0.98) 
213.5 µm 
52.2 
(30.6 - 73.2) 
3.9 0.2 
T 
0.84 
(0.73-0.96) 
93.5 µm 
56.5 
(34.5 - 76.8) 
4.4 0.2 
 
*For all measurements, specificity (95% CI) was set to 96.4% (81.7%-99.9%). 
PE: papilledema; PPE: pseudopapilledema; AUC: area under the ROC curve; ONSD: 
optic nerve sheath diameter; S, N, I, T: superior, nasal, inferior, and temporal quadrant 
RNFLT; LR+: positive likelihood ratio, LR-: negative likelihood ratio. 
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Figure 3. ROC curve for ONSD, 30o test and avg RNFLT in differentiating (A) all PE eyes 
(Frisen I to IV) and (B) mild PE eyes (Frisen I & II) from PPE.  
Relationship between various measurements in PE 
 Spearman’s Rho (rho) was used to assess the correlation between the lumbar 
puncture (LP) opening pressure and various ultrasound and OCT measurements (Figure 
4).  There was no observable correlation between LP opening pressure and ONSD (rho 
= 0.01, p = 0.95), 30° test (rho = 0.22, p = 0.31), or avg RNFLT (r = 0.17, p = 0.44), 
(Figure 4A-C).  However, significant correlation was seen between LP opening pressure 
and the Frisen scale (rho = 0.48, p = 0.019) (Figure 4D).  
Positive correlation was seen between the avg RNFLT and ONSD (rho = 0.49, p 
= 0.018) (Figure 5A), but not between avg RNFLT and 30° test (rho = 0.14, p = 0.54) 
(Figure 5B). Frisen scale grading correlated with both ONSD (rho = 0.52, p = 0.011) 
(Figure 5C) and avg RNFLT (rho = 0.70, p = 0.0002) (Figure 5D).   
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Figure 4. Scatter plot showed no observable correlation between LP opening pressure 
and (A) ONSD (rho = 0.01, p = 0.95), (B) 30° test (rho = 0.22, p = 0.31 B), or (C) avg 
RNFLT (rho = 0.17, p = 0.44, C). However, a significant correlation was seen between 
(D) LP opening pressure and the Frisen scale (rho = 0.48, p = 0.019, D). 
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Figure 5. Scatterplots showed correlation between avg RNFLT and ONSD (A: rho = 
0.49, p = 0.018), but not between avg RNFLT and 30o test (B: rho = 0.14, p = 0.54). 
Frisen scale grading correlated with both ONSD (C: rho = 0.52, p = 0.011) and RNFLT 
(D: rho = 0.70, p = 0.0002). 
 
Interocular Asymmetry 
 
 
Among the 23 patients with PE, 26.1% (n = 6) showed one grade of interocular 
difference in Frisen scale, and 8.7% (n = 2) showed two grades of difference.  Figure 6 
shows a scatter plot of ONSD (A) and avg RNFLT (B) from each eye (filled and open 
symbols for PE and PPE, respectively) with the solid diagonal line indicating equal 
values between the two eyes. Compared to PPE, the amount of interocular asymmetry 
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was much more noticeable for avg RNFLT than for ONSD.  In Figure 6C, the interocular 
avg RNFLT difference was plotted against the interocular ONSD difference with dashed 
lines indicating zero difference in ONSD (vertical dashed line) and avg RNFLT 
(horizontal dashed line).  Ten (43.5%) PE patients showed RNFLT difference exceeding 
the range of PPE patients whereas only 3 (13.0%) patients’ ONSD difference exceeded 
the range in PPE. 
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Figure 6. ONSD (A) and avg RNFLT (B) in OD was plotted against that in OS, with each 
data point representing an individual patient.  The solid diagonal line indicates equal 
values between the two eyes.  C. Interocular avg RNFLT difference was compared to 
interocular ONSD difference, with dashed lines indicating zero difference in avg RNFLT 
(horizontal dashed line) and ONSD (vertical dashed line). Compared to PPE (open 
symbols), the amount of interocular asymmetry for PE was much more noticeable for 
avg RNFLT than for ONSD.   
 
 
 
 
 
 
 30 
Chapter 4: Discussion 
Both ultrasound and OCT provided useful information for differentiating between 
PE and PPE in a group of patients referred to the neuro-ophthalmological service for 
suspected PE. However, ONSD and the 30° test showed better diagnostic abilities than 
OCT in distinguishing PE from PPE. 
The ONSD and the 30° test in PE and PPE 
The 91.3% sensitivity of ONSD and the 30° test in our study compare favorably 
with studies done by Carter et al (13) and Neudorfer et al (12), who found a sensitivity of 
90% and 85%, respectively. Our study showed a higher specificity (96%) when 
compared to both studies (63-79%). To classify a positive ultrasound test, Carter et al 
used both the ONSD > 3.3 mm and a positive 30° test (>10% change in ONSD) and 
found a specificity of 79% in an adult population: whereas Neudorfer, in a pediatric 
population, only used ONSD > 3.3 mm and reported a specificity of 63%. For our study, 
if the > 10% criterion was used, the 30° test showed 91.3% sensitivity and 85.7% 
specificity. The difference in the study population, the severity of the PE along with the 
ultrasonagrapher’s experience could all contribute to the difference in specificities.  The 
optimum cut-off based on the current study cohort was > 4.59 mm for ONSD and > 
13.5% for 30° test, although individual labs should have their own values established.  
Of the 23 PE patients, two (9%) had normal ONSD. The first was a 35-year-old 
obese (BMI = 35) female who presented with headaches, tinnitus, and transient visual 
obscurations.  Examination showed a Frisen grade II PE, 4.34 mm ONSD, a negative 
30° test (3%), normal avg RNFLT, a thickened (> 95% age-matched machine norm) 
inferior RNFLT, and elevated LP OP (29 cm of H20). This patient shows that in some 
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individuals, the CSF along the retrobulbar optic nerve sheath might be minimal despite 
an increased ICP. There may be restriction of CSF as it passes from the chiasmal 
cistern through the optic canal into the perioptic subarachnoid space. A smaller optic 
canal (93), whether congenital or secondary to a meningiothelial cell overgrowth (94), or 
a very dense network of arachnoid trabeculae and septae could be preventing the facility 
of CSF into the perioptic subarachnoid space (18, 95).  
The second patient, a 16-year-old overweight (BMI = 27) female, presented with 
headaches, Frisen grade I PE, 4.38 mm ONSD, a positive 30° test (17%), normal avg 
RNFLT, a thickened inferior RNFLT, and a borderline lumbar puncture (22 cm of H2O). 
Treatment was initiated and over the following 8 months, there was marked 
improvement in symptoms and optic nerve head appearance (avg RNFLT decreasing 
from 108 to 95 µm). There is a normal variation in ONSDs (96) and it is important for 
clinicians to be aware that some patients can have a lower pre-morbid ONSD.  This is a 
case in which the 30° test, although difficult to perform, was helpful in making the correct 
diagnosis. These two cases demonstrate some of the limitations of orbital ultrasound 
and the difficulty in diagnosing accurately all PE patients.  Clinicians should integrate 
clinical history with exam findings and order further testing if there is a strong suspicion 
of PE despite a negative orbital ultrasonography finding. 
Of the PPE patients, only one (4%), a 12-year old male presenting with 
headaches, had a large ONSD (4.61mm).  Examination showed large buried drusen, a 
negative 30° test (6%), and a thickened avg RNFLT.  This rare phenomenon of PPE 
patients presenting with larger than normal ONSD has been reported in previous studies 
(12, 13).  In a case report by Sadda et al, a symptomatic PPE patient with an enlarged 
ONSD underwent three normal lumbar punctures over an eight year period with no 
improvement in symptoms or optic nerve appearance (97). This could also be attributed 
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to a normal variation in anatomy and/or optic nerve sheath compliance (68), which 
means it is possible to have a relatively large ONSD despite a normal ICP.  Although our 
study couldn’t prove that the 30° test performed better than ONSD, this finding would 
lead one to believe that the 30° test could perform better than the ONSD in detecting PE 
from PPE.  Nevertheless, orbital ultrasonography is a very useful test in differentiating 
PE from PPE; the three cases discussed above emphasize that orbital ultrasonography 
should not be used in isolation for diagnosing PE or PPE.  
OCT in PE and PPE 
Similar to our study, previous OCT studies have found an increase in the avg and 
quadrant RNFL thicknesses in optic disc edema compared to pseudo optic disc edema 
(76-79). Unlike our study where we examined only PE, most of these studies included a 
heterogeneous group of optic disc edema including PE, ischemic optic neuropathies, 
and optic neuritis and used various types of OCT machines (Table. 4) making direct 
comparisons difficult. Despite that, the diagnostic performance (AUC) for the RNFL 
thickness is similar in the current study (0.83 to 0.90) and several previous reports (0.73 
to 0.87, except 0.64 at nasal quadrant in Bassi et al 2014) (11, 76, 77, 79). However, 
one Cirrus OCT study by Flores et al, in which the PPE group consisted of buried and 
surface drusen, reported higher AUC values (0.92 to 0.97), which is likely due to a 
relatively thin RNFL thickness in their optic drusen group (88 µm avg RNFL compared to 
102 - 128 µm in other studies, Table 4) (78). RNFL thinning can be associated with optic 
disc drusen (98, 99); however, of the 13 optic drusen eyes in our study, only one eye 
showed abnormally thin avg RNFL thickness (exceeding 99% age-matched machine 
norms) and our mean avg RNFL thickness was 104.9 µm.  Our buried drusen RNFLT 
measurements compared similarly with Kulkarni et al (all quadrants within 15 µm) (84), 
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but Lee et al, who had a larger group (n = 58) of buried drusen patients measured with 
SD-OCT, showed a thicker temporal RNFLT (110 µm) compared to our temporal RNFLT 
(66 µm) (86).  Lee et al, found that larger buried drusen cause an increase in temporal 
RNFLT, thus one possibility is that the Lee study had larger sized buried drusen 
compared to our study. The average age in the Lee study was 13.5 years old compared 
to 26.8 years in ours.  Thus, another possibility is that the buried drusen in our study, 
with time, are causing a focal axonal degeneration attributing to the decreased RNFLT 
temporally.  Since buried drusen have many different presentations, in our experience, it 
presents as one of the most challenging situations when differentiating between PPE 
and PE, especially if the clinician doesn’t have the equipment to perform a B-scan in 
office.  
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Some authors have suggested that the RNFL thickening in the nasal quadrant 
has the greatest diagnostic value (76, 77, 79); however, our data did not show a 
statistically significant difference in the AUCs among various quadrants. In our study, the 
AUC was the highest (0.90) for the inferior quadrant RNFL; supporting Dr. Hayreh’s 
observation that “optic disc edema in raised intracranial pressure first appeared at the 
lower pole” in the monkey model (18). Dr. Hayreh proposed that the regions with thicker 
fibers in normal eyes such as the inferior quadrant (100) are more prone to axoplasmic 
flow stasis, resulting in early optic disc edema.  
Ultrasound and OCT in differentiating mild PE (Frisen I and II) from PPE 
In our study, both ultrasound (ONSD or 30° test) and OCT (avg or quadrant 
RNFLT) correctly diagnosed all PE eyes with Frisen scale III and IV. However, we 
recognize that the real diagnostic challenge for eye care providers lies in differentiating 
between mild PE and PPE. We did additional analysis (Table 5) by comparing the 15 PE 
eyes with Frisen scale I and II (if both eyes of an individual meet the criteria, the eye with 
lower RNFLT was chosen) to the PPE group (in each individual, the eye with higher 
RNFLT was chosen). Compared to all PE eyes included, the ultrasound showed slightly 
reduced AUC and sensitivity (at 96.4% specificity): 0.95 AUC and 80% sensitivity for the 
ONSD, 0.93 and 86.7% for the 30° test (Figure 3B and Table 5). For RNFLT, the AUC 
decreased to 0.61 - 0.77; sensitivity at 96.4% specificity ranged from 6.7% to 13.3%, 
showing very poor performance. Recently a small study by Kulkarni et al included 9 mild 
PE and 6 PPE patients and showed no difference in RNFLT between the two groups 
(84), but our study showed a statistical difference in the mean values (Table 5) of avg, 
superior, and inferior RNFLT in mild PE compared to the respective values in the PPE 
group. 
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Table 5: Diagnostic performance for ultrasound and OCT in differentiating mild PE (Fr I-
II) from PPE 
 
 Mean Values for Mild 
PE (n=15) 
AUC 
(95% CI) 
Cutoff 
value 
Sensitivity%* 
(95% CI) 
ONSD 4.97±0.43 mm 
0.95 
(0.89-1.02) 
4.59 mm 
80.0 
(51.9-95.7) 
30o test 20.13±9.26% 
0.93 
(0.84-1.03) 
13.50% 
86.7 
(59.5-98.4) 
Avg 
RNFLT 
121.6±33.76 µm 
0.71 
(0.55-0.87) 
146.5 µm 
13.3 
(16.6-40.5) 
S 150.53±56.47 µm 
0.64 
(0.44-0.83) 
154.0 µm 
40.0 
(16.3-67.7) 
N 105.80±51.96 µm 
0.77 
(0.62-0.93) 
202.0 µm 
6.7 
(0.2-32.0) 
I 159.87±40.97 µm 
0.70 
(0.54-0.86) 
213.5 µm 
6.7 
(0.2-32.0) 
T 70.47±15.55 µm 
0.61 
(0.43-0.79) 
105.5 µm 
6.7 
(0.2-32.0) 
*For all measurements, specificity (95% CI) was set to 96.4% (81.7%-99.9%).  
Fr I-II: Frisen scale I-II; PE: papilledema; PPE: pseudopapilledema; AUC: area under the 
curve; S, N, I, T: superior, nasal, inferior, and temporal quadrant RNFL thickness. 
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 Considering the disease mechanism of PE and PPE, it is not surprising that the 
ultrasound performed much better than OCT in differentiating mild PE from PPE. In PE, 
the elevated ICP is first transmitted to the perioptic subarachnoid space, causing an 
increase in ONSD, which then cause axoplasmic flow stasis and subsequent swelling of 
the RNFL (18). In some eyes with good optic nerve sheath compliance, when the 
perioptic CSF pressure is mild to moderate, the sheath expansion might balance out 
some of the pressure rise, leading to only mild axonal swelling anteriorly.  In PPE, the 
anatomical changes occur anteriorly in the optic disc (drusen lie anteriorly to lamina 
cribrosa affecting OCT measurements) (35), not affecting the retrobulbar optic nerve 
sheath. 
 
Retinal ganglion cell integrity in PE and PPE 
 
As GCIPT is a sensitive measurement in glaucoma (101) and multiple sclerosis 
(102); we also examined GCIPT in PE for potential ganglion cell loss.  The GCIP layer 
proved to have no diagnostic value, and was neither increased nor decreased in PE. It is 
worth mentioning that the GCIPT at the initial visit in 26% PE patients (n = 6/23) were 
flagged as “red” (below 99% of the machine normative values) that was due to 
inaccurate segmentation, despite great signal strength.  Once the PE had resolved, 
which occurred in all patients, the GCIPT returned to “normal” when compared to age 
matched norms.  Clinicians and researchers should take caution when reporting and 
monitoring these values.  
 
Relationship between various measurements in PE 
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In our study, Frisen scale was moderately correlated with LP opening pressure 
(Spearman rho = 0.48), ONSD (rho = 0.52) and avg RNFLT (rho = 0.70), suggesting a 
general trend of more severe PE in those with higher LP opening pressure. However, a 
correlation between LP opening pressure and ONSD or RNFLT was not observed.  The 
lack of a correlation could be attributed to the fact that ocular measurements and LP 
were not performed at the same time. However, the concept of uniformly distributed CSF 
pressure in patients with PE is challenged by the presence of asymmetric and unilateral 
PE (see section below), absence of PE in some patients with raised ICP (103), and the 
persistence of PE in some with normalized ICP (104). Killer et al proposed the idea of 
“compartment” of the perioptic subarachnoid spaces, as evidenced by the markedly 
different CSF protein concentrations in the lumbar CSF and perioptic CSF in patients 
with PE (105), and reduced perioptic CSF flow compared to that in suprasellar cistern in 
some IIH patients (106).  In other words, the perioptic CSF pressure causing PE is not 
necessarily expected to be equal to that of LP opening pressure; therefore, a nice 
correlation between LP opening pressure and ONSD or RNFLT may not exist. 
 
Asymmetry in PE 
 
Previous studies reported that 4 - 7.5% of PE patients exhibit very asymmetric 
PE (defined as ≥ 2 Frisen scale difference) (54, 93).  In our study, 2 (8.7%) PE patients 
met the criterion of severe asymmetry (grade II Frisen scale in one eye and IV in 
contralateral eye). The mechanism underlying the asymmetry is unsettled. Lepore 
(1992) proposed the role of bilateral differences in collagen thickness and elasticity at 
the lamina cribrosa or the optic nerve sheath (4), while others (93, 104) suggested optic 
canal anatomy as a contributing factor. Based on brain imaging of those with very 
asymmetric PE, Bidot et al (2014) found smaller optic canals on the side with less optic 
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disc edema in all (8 out of 8) and less perioptic nerve CSF in 50% (6 of 12) of the 
subjects (93). They believed that the smaller optic canal restricts the amount of CSF 
transmitted to the perioptic subarachnoid space, resulting in less disc edema. It is 
unclear if the smaller optic canal is congenital or acquired, for example, meningiothelial 
cells may play a role since they proliferate in response to elevated ICP (94) and could 
potentially decrease the optic canal size to variable degrees between the eyes. 
Interestingly, 43.5% (10/23) of our patients showed RNFL asymmetry exceeding the 
difference in control (PPE), however, only 8.7% (2/23) patients had ONSD difference 
larger than the range in control. The two patients with very asymmetric PE showed 8.5% 
and 4.7% interocular difference in ONSD (difference/mean size) compared to 51.4% and 
43.8% RNFLT difference. Our data is in agreement with the report by Huna-Baron et al 
(2001) where neuroimaging in 15 patients with unilateral PE did not show a gross 
difference (none larger than 0.5 mm) in ONSD (107), supporting that factors such as 
difference in lamina cribrosa might play a role.  However, our finding doesn’t necessarily 
contradict the hypothesis of asymmetrical preoptic pressure secondary to different optic 
canal sizes. It is plausible that after the optic nerve sheath distension reaches its limit 
bilaterally (68), the side with higher perioptic CSF pressure would lead to greater disc 
swelling. It is also possible that the ultrasound is not as sensitive as OCT in detecting 
interocular differences.  Further research may shed light into this topic, which has 
particular interest in astronauts, where it has been reported that 4 of 7 astronauts had 
asymmetric PE, all worse in the right eye (108).   
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Limitations of current study and future direction 
The limitations of the present study include the retrospective nature, relatively 
small sample size, potential sampling bias, and the physician being unmasked to 
ultrasound and OCT results.  Since this study was done with patients from a tertiary 
neuro-ophthalmologist, our results were skewed towards cases with difficult diagnostic 
decisions, especially in the PPE group.  Compared to Carter et al, where 67% of PPE 
patients were asymptomatic (13), every PPE patient presented with at least one 
symptom (HA, TVO, tinnitus), which is what warranted the referral. Our neuro-
ophthalmologist is fully aware that IIH can occur without PE (103), therefore, careful 
analysis of clinical history, symptomology, when necessary communication with their 
neurologists or internists, and observation over time were conducted to minimize the 
number of false negatives.      
Even though orbital ultrasound was superior to SD-OCT in differentiating PE and 
PPE, very few eye care providers have access to a highly trained ultrasonagrapher who 
can perform the standardized A scan; therefore, we are currently investigating whether 
same results are achievable using B scan, a much easier and faster technique to 
measure ONSD (66). Two recent meta-analysis have shown that in neuro-intensive 
units, it can accurately diagnose PE compared to normal controls with good sensitivity 
(90-96%) and specificity (85-92%) (65, 109). These studies do report different ONSD 
thresholds and thus internal validation should be considered before implementing B-
scan in the diagnosis of elevated ICP (64).   
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Chapter 5: Conclusion 
 
 The purpose of this thesis was to evaluate the use of two non-invasive and low-
cost tests, orbital ultrasound and optical coherence tomography, in differentiating 
papilledema (PE) from pseudopapilledema (PPE). 
Accurately differentiating PE from PPE is critical because PE indicates potentially 
life-threatening conditions requiring urgent medical management whereas PPE is a 
benign condition.  Making a decision based on ophthalmoscopy alone can be difficult 
because optic discs in PE and PPE could both appear elevated, crowded, and have 
indistinct margins.  Knowledge gained from this research will aid clinicians in correctly 
diagnosing PE especially mild PE, which will facilitate early detection and treatment of 
ocular or systemic health conditions.  
Previous studies have examined the role of optical coherence tomography (OCT) 
or ultrasound individually in differentiating PE and PPE; however, to our knowledge, this 
was the first study to include both SD-OCT and standardized A-scan in the same group 
of patients. If we can improve diagnostic accuracy based on objective, low-cost, non-
invasive, clinically available devices such as OCT and orbital ultrasound, we will 
decrease or completely avoid expensive, invasive, unnecessary testing, and 
patient/doctor anxiety. 
The main findings of this thesis are as follows: 
• Since all of our patients were diagnosed with IIH, most of the patients 
in the PE subgroup were females of childbearing age.  The most 
common symptom was headache, followed by TVO and tinnitus; 
symptoms showed no statistical difference in differentiating between 
PE and PPE. However, such finding may not apply to a general clinic. 
A high prevalence of symptoms in our PPE group is likely a reflection 
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of these patients being referred to a tertiary neuro-ophthalmology 
clinic. 
• Mean ONSD and avg RNFLT measurements were greater in PE than 
PPE.  A greater reduction on the 30° test was seen in PE compared to 
PPE 
• Of all the orbital ultrasound and OCT measurements, ONSD and the 
30° test showed the greatest diagnostic capabilities followed by the 
inferior RNFLT and avg RNFLT. 
• In several PE patients, OCT showed GCIPT thinning on the initial 
visit; however, once the PE had resolved, which occurred in all 
patients, the GCIPT returned to “normal” when compared to age 
matched norms.  Clinicians and researchers should take caution in 
interpreting this inaccurate segmentation as atrophy when reporting 
and monitoring these values.  
• Our study supports orbital ultrasonography and SD-OCT as useful 
ancillary tests that can be done, along with a thorough examination, in 
order to effectively differentiate between PE and PPE.  Due to its easy 
access, OCT scan of RNFL thickness can be potentially used to 
detect moderate to severe papilledema in a non-ophthalmologic 
setting.  Ultrasound measurements may further assist eye care 
providers in differentiating mild PE from PPE when ophthalmoscopic 
findings are non-diagnostic.   
• A future, prospective trial is needed to confirm the diagnostic abilities 
of OCT and orbital ultrasonography in differentiating PE from PPE. 
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